Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yuhei Ito, Machiko Arita, Shogo Kumagai, Reoto Takei, Maki Noyama, Fumiaki Tokioka, Keisuke Nishimura, Takashi Koyama, Hiromasa Tachibana & Tadashi Ishida. (2019) Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease. Modern Rheumatology 29:1, pages 98-104.
Read now
Read now
Olivier Ethgen, Frédéric de Lemos Esteves, Olivier Bruyere & Jean-Yves Reginster. (2013) What do we know about the safety of corticosteroids in rheumatoid arthritis?. Current Medical Research and Opinion 29:9, pages 1147-1160.
Read now
Read now
B-M Nyhäll-Wåhlin, IF Petersson, C Jacobsson, P Geborek, J-Å Nilsson, K Nilsson, LTH Jacobsson & C Turesson. (2012) Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors. Scandinavian Journal of Rheumatology 41:6, pages 434-437.
Read now
Read now
Kumi Shidara, Daisuke Hoshi, Eisuke Inoue, Toru Yamada, Ayako Nakajima, Atsuo Taniguchi, Masako Hara, Shigeki Momohara, Naoyuki Kamatani & Hisashi Yamanaka. (2010) Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Modern Rheumatology 20:3, pages 280-286.
Read now
Read now
Articles from other publishers (68)
Scott M. Matson & M. Kristen Demoruelle. (2023) Connective Tissue Disease Associated Interstitial Lung Disease. Immunology and Allergy Clinics of North America 43:2, pages 229-244.
Crossref
Crossref
Richard Conway & Elena Nikiphorou. (2023) Efficacy and safety of conventional synthetic, biologic and targeted synthetic DMARDs in RA-ILD: A narrative review. Indian Journal of Rheumatology 0:0, pages 0.
Crossref
Crossref
Philippe Bonniaud & Philippe Camus. 2023. Orphan Lung Diseases. Orphan Lung Diseases
735
775
.
Joshua J. Solomon, Kevin Brown & Mary Kristen Demoruelle. 2023. Orphan Lung Diseases. Orphan Lung Diseases
207
221
.
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández & José Antonio Rodríquez Portal. (2022) SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatología Clínica (English Edition) 18:9, pages 501-512.
Crossref
Crossref
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández & José Antonio Rodríquez Portal. (2022) Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento. Reumatología Clínica 18:9, pages 501-512.
Crossref
Crossref
Scott M. Matson & Joyce S. Lee. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
307
318
.
Meihua Qiu, Jing Jiang, Xueyuan Nian, Yutie Wang, Pengfei Yu, Jie Song & Shenchun Zou. (2021) Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respiratory Research 22:1.
Crossref
Crossref
Shamma Ahmad Al Nokhatha, Robert Harrington & Richard Conway. (2021) Le méthotrexate est-il contre-indiqué dans les atteintes pulmonaires de la polyarthrite rhumatoïde ?. Revue du Rhumatisme 88:6, pages 399-401.
Crossref
Crossref
Shinji Izuka, Hiroyuki Yamashita, Arisa Iba, Yuko Takahashi & Hiroshi Kaneko. (2021) Acute exacerbation of rheumatoid arthritis–associated interstitial lung disease: clinical features and prognosis. Rheumatology 60:5, pages 2348-2354.
Crossref
Crossref
Vanessa L. Kronzer, Weixing Huang, Paul F. Dellaripa, Sicong Huang, Vivi Feathers, Bing Lu, Christine K. Iannaccone, Ritu R. Gill, Hiroto Hatabu, Mizuki Nishino, Cynthia S. Crowson, John M. DavisIIIIII, Michael E. Weinblatt, Nancy A. Shadick, Tracy J. Doyle & Jeffrey A. Sparks. (2021) Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. The Journal of Rheumatology 48:5, pages 656-663.
Crossref
Crossref
Joanna Kur-Zalewska, Bartłomiej Kisiel, Marta Kania-Pudło, Małgorzata Tłustochowicz, Andrzej Chciałowski & Witold Tłustochowicz. (2021) A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients. PLOS ONE 16:4, pages e0250339.
Crossref
Crossref
Manal Shawky Hussein, Amal Mohamad El‐Barbary, Doaa Waseem Nada, Rasha Ahmad Gaber, Reham Mohamed Elkolaly & Marwa Ahmed Aboelhawa. (2021) Identification of serum interleukin‐13 and interleukin‐13 receptor subunit expressions: Rheumatoid arthritis–associated interstitial lung disease. International Journal of Rheumatic Diseases 24:4, pages 591-598.
Crossref
Crossref
Else Helene Ibfelt, Rikke Kart Jacobsen, Tine Iskov Kopp, René Lindholm Cordtz, Anna Svarre Jakobsen, Niels Seersholm, Saher Burhan Shaker & Lene Dreyer. (2021) Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatology 60:1, pages 346-352.
Crossref
Crossref
Ho Cheol Kim, Jeong Seok Lee, Eun Young Lee, You‐Jung Ha, Eun Jin Chae, Minkyu Han, Gary Cross, Joseph Barnett, Jacob Joseph & Jin Woo Song. (2020) Risk prediction model in rheumatoid arthritis‐associated interstitial lung disease. Respirology 25:12, pages 1257-1264.
Crossref
Crossref
Shamma Ahmad Al Nokhatha, Robert Harrington & Richard Conway. (2020) Is methotrexate contra-indicated in lung involvement of rheumatoid arthritis?. Joint Bone Spine 87:6, pages 535-537.
Crossref
Crossref
Sicong Huang, Vanessa L. Kronzer, Paul F. Dellaripa, Kevin D. Deane, Marcy B. Bolster, Vivek Nagaraja, Dinesh Khanna, Tracy J. Doyle & Jeffrey A. Sparks. (2020) Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment. Current Treatment Options in Rheumatology 6:4, pages 337-353.
Crossref
Crossref
Susan M. Goodman. 2020. Perioperative Care of the Orthopedic Patient. Perioperative Care of the Orthopedic Patient
153
166
.
Emily K. Wu, Zoe I. Henkes, Brion McGowan, Richard D. Bell, Moises J. Velez, Alexandra M. Livingstone, Christopher T. Ritchlin, Edward M. Schwarz & Homaira Rahimi. (2019) TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23− B Cell Follicles Is Prevented with Anti-TNF Therapy. The Journal of Immunology 203:11, pages 2837-2849.
Crossref
Crossref
George E Fragoulis, Richard Conway & Elena Nikiphorou. (2019) Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature. Rheumatology 58:11, pages 1900-1906.
Crossref
Crossref
Patrick Kiely, A D Busby, E Nikiphorou, K Sullivan, D A Walsh, P Creamer, J Dixey & A Young. (2019) Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open 9:5, pages e028466.
Crossref
Crossref
Philippe Bonniaud, Guillaume Beltramo, Clément Foignot, Paul Ornetti & Marjolaine Georges. (2018) Pneumopathies non infectieuses induites par les biothérapies ciblées. Revue du Rhumatisme Monographies 85:3, pages 184-190.
Crossref
Crossref
Meghna Jani, William G. Dixon & Eric L. Matteson. 2018. Lung Disease in Rheumatoid Arthritis. Lung Disease in Rheumatoid Arthritis
121
161
.
M. Kristen Demoruelle, Amy L. Olson & Joshua J. Solomon. 2018. Lung Disease in Rheumatoid Arthritis. Lung Disease in Rheumatoid Arthritis
45
58
.
Hanna M. Nurmi, Minna K. Purokivi, Miia S. Kärkkäinen, Hannu-Pekka Kettunen, Tuomas A. Selander & Riitta L. Kaarteenaho. (2017) Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
Lisa Theander, Britt-Marie Nyhäll-Wåhlin, Jan-Åke Nilsson, Minna Willim, Lennart T.H. Jacobsson, Ingemar F. Petersson & Carl Turesson. (2017) Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors. The Journal of Rheumatology 44:7, pages 981-987.
Crossref
Crossref
Julie Morisset, Eric Vittinghoff, Bo Young Lee, Roberto Tonelli, Xiaowen Hu, Brett M. Elicker, Jay H. Ryu, Kirk D. Jones, Stefania Cerri, Andreina Manfredi, Marco Sebastiani, Andrew J. Gross, Brett Ley, Paul J. Wolters, Talmadge E. KingJr.Jr., Dong Soon Kim, Harold R. Collard & Joyce S. Lee. (2017) The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respiratory Medicine 127, pages 51-56.
Crossref
Crossref
Zulma X. Yunt, Jonathan H. Chung, Stephen Hobbs, Evans R. Fernandez-Perez, Amy L. Olson, Tristan J. Huie, Rebecca C. Keith, William J. Janssen, Barbara L. Goldstein, David A. Lynch, Kevin K. Brown, Jeffrey J. Swigris & Joshua J. Solomon. (2017) High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival. Respiratory Medicine 126, pages 100-104.
Crossref
Crossref
Jeffrey R. Curtis, Khaled Sarsour, Pavel Napalkov, Laurie A. Costa & Kathy L. Schulman. (2015) Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study. Arthritis Research & Therapy 17:1.
Crossref
Crossref
S. Clerc & P. Camus. (2015) Complications pulmonaires des traitements des maladies systémiques. Revue des Maladies Respiratoires Actualités 7:2, pages 126-129.
Crossref
Crossref
Ayako Nakajima, Eisuke Inoue, Yoko Shimizu, Akiko Kobayashi, Kumi Shidara, Naoki Sugimoto, Yohei Seto, Eiichi Tanaka, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2014) Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis. Clinical Rheumatology 34:3, pages 441-449.
Crossref
Crossref
Shunsuke Mori. (2015) Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23288.
Crossref
Crossref
Chuan-Guo Du. (2015) A Retrospective Study of Clinical Characteristics of Interstitial Lung Disease Associated with Rheumatoid Arthritis in Chinese Patients. Medical Science Monitor 21, pages 708-715.
Crossref
Crossref
Renzo Pérez-Dórame, Mayra Mejía, Heidegger Mateos-Toledo & Jorge Rojas-Serrano. (2015) Rheumatoid arthritis-associated interstitial lung disease: Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity. Reumatología Clínica (English Edition) 11:1, pages 12-16.
Crossref
Crossref
Renzo Pérez-Dórame, Mayra Mejía, Heidegger Mateos-Toledo & Jorge Rojas-Serrano. (2015) Rheumatoid arthritis-associated interstitial lung disease: Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity. Reumatología Clínica 11:1, pages 12-16.
Crossref
Crossref
Antonio Mera-Varela & Eva Pérez-Pampín. (2014) Abatacept Therapy in Rheumatoid Arthritis With Interstitial Lung Disease. Journal of Clinical Rheumatology 20:8, pages 445-446.
Crossref
Crossref
Jorge Rojas-Serrano, Heidegger Mateos-Toledo & Mayra Mejía. (2014) Methotrexate and Lung Disease in Rheumatoid Arthritis: Comment on the Article by Conway et al. Arthritis & Rheumatology 66:9, pages 2641-2642.
Crossref
Crossref
Deborah Assayag, Molly Lubin, Joyce S. Lee, Talmadge E. King, Harold R. Collard & Christopher J. Ryerson. (2014) Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology 19:4, pages 493-500.
Crossref
Crossref
Meghna Jani, Nik Hirani, Eric L. Matteson & William G. Dixon. (2013) The safety of biologic therapies in RA-associated interstitial lung disease. Nature Reviews Rheumatology 10:5, pages 284-294.
Crossref
Crossref
Camille Roubille & Boulos Haraoui. (2014) Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review. Seminars in Arthritis and Rheumatism 43:5, pages 613-626.
Crossref
Crossref
Robert W. Hallowell & Maureen R. Horton. (2014) Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced. Drugs 74:4, pages 443-450.
Crossref
Crossref
Maurizio Cutolo, George D. Kitas & Piet L.C.M. van Riel. (2014) Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint. Seminars in Arthritis and Rheumatism 43:4, pages 479-488.
Crossref
Crossref
Susan M. Goodman. 2014. Perioperative Care of the Orthopedic Patient. Perioperative Care of the Orthopedic Patient
113
124
.
Carl Turesson. (2013) Extra-articular rheumatoid arthritis. Current Opinion in Rheumatology 25:3, pages 360-366.
Crossref
Crossref
Lisa J. Herrinton, Leslie R. Harrold, Liyan Liu, Marsha A. Raebel, Ananse' Taharka, Kevin L. Winthrop, Daniel H. Solomon, Jeffrey R. Curtis, James D. Lewis & Kenneth G. Saag. (2013)
Association between anti‐TNF‐
α
therapy and interstitial lung disease
. Pharmacoepidemiology and Drug Safety 22:4, pages 394-402.
Crossref
Crossref
Shunsuke Mori, Yukinori Koga & Mineharu Sugimoto. (2012) Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respiratory Medicine 106:11, pages 1591-1599.
Crossref
Crossref
Sarah C Horton, Jackie L Nam & Maya H Buch. (2012) Safety of biologics in rheumatoid arthritis. International Journal of Clinical Rheumatology 7:4, pages 425-451.
Crossref
Crossref
Jorge Rojas-Serrano, Edilzar González-Velásquez, Mayra Mejía, Alain Sánchez-Rodríguez & Guillermo Carrillo. (2012) Interstitial Lung Disease Related to Rheumatoid Arthritis: Evolution After Treatment. Reumatología Clínica (English Edition) 8:2, pages 68-71.
Crossref
Crossref
Jorge Rojas-Serrano, Edilzar González-Velásquez, Mayra Mejía, Alain Sánchez-Rodríguez & Guillermo Carrillo. (2012) Interstitial lung disease related to rheumatoid arthritis: Evolution after treatment. Reumatología Clínica 8:2, pages 68-71.
Crossref
Crossref
Takuma WADA, Yuji AKIYAMA, Kazuhiro YOKOTA, Kojiro SATO, Yu FUNAKUBO & Toshihide MIMURA. (2012) A case of rheumatoid arthritis complicated with deteriorated interstitial pneumonia after the administration of abataceptアバタセプト投与後に肺間質影が増悪した関節リウマチの1例. Japanese Journal of Clinical Immunology 35:5, pages 433-438.
Crossref
Crossref
Roberto Perez-Alvarez, Marta Perez-de-Lis, Candido Diaz-Lagares, Jose M. Pego-Reigosa, Soledad Retamozo, Albert Bove, Pilar Brito-Zeron, Xavier Bosch & Manuel Ramos-Casals. (2011) Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases. Seminars in Arthritis and Rheumatism 41:2, pages 256-264.
Crossref
Crossref
Stylianos T. Panopoulos & Petros P. Sfikakis. (2011) Biological treatments and connective tissue disease associated interstitial lung disease. Current Opinion in Pulmonary Medicine 17:5, pages 362-367.
Crossref
Crossref
Nicola J. Gullick & David L. Scott. (2011) Co-morbidities in established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 25:4, pages 469-483.
Crossref
Crossref
ELENA MYASOEDOVA, CYNTHIA S. CROWSON, CARL TURESSON, SHERINE E. GABRIEL & ERIC L. MATTESON. (2011) Incidence of Extraarticular Rheumatoid Arthritis in Olmsted County, Minnesota, in 1995–2007 Versus 1985–1994: A Population-based Study. The Journal of Rheumatology 38:6, pages 983-989.
Crossref
Crossref
Ronald F. van Vollenhoven. (2011) Unresolved issues in biologic therapy for rheumatoid arthritis. Nature Reviews Rheumatology 7:4, pages 205-215.
Crossref
Crossref
JUSTINE V. COHEN, BRIAN C. CAPELL, PAUL A. KINNIRY & ALAN L. EPSTEIN. (2011) Rapidly Fatal Pulmonary Fibrosis in a Patient with Psoriatic Arthritis Treated with Adalimumab. The Journal of Rheumatology 38:2, pages 398-399.
Crossref
Crossref
Kosaku Komiya, Hiroshi Ishii, Naoko Fujita, Hiroaki Oka, Atsuko Iwata, Hisako Sonoda & Jun-ichi Kadota. (2011) Adalimumab-induced Interstitial Pneumonia with an Improvement of Pre-existing Rheumatoid Arthritis-associated Lung Involvement. Internal Medicine 50:7, pages 749-751.
Crossref
Crossref
Atul A. Khasnis & Leonard H. Calabrese. (2010) Tumor Necrosis Factor Inhibitors and Lung Disease: A Paradox of Efficacy and Risk. Seminars in Arthritis and Rheumatism 40:2, pages 147-163.
Crossref
Crossref
Danielle Antin-Ozerkis, Janine Evans, Ami Rubinowitz, Robert J. Homer & Richard A. Matthay. (2010) Pulmonary Manifestations of Rheumatoid Arthritis. Clinics in Chest Medicine 31:3, pages 451-478.
Crossref
Crossref
Z. L. McLaren & J. K. Dawson. (2010) Comment on: Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. Rheumatology 49:8, pages 1606-1606.
Crossref
Crossref
G. Koduri, S. Norton, A. Young, N. Cox, P. Davies, J. Devlin, J. Dixey, A. Gough, P. Prouse, J. Winfield & P. Williams. (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 49:8, pages 1483-1489.
Crossref
Crossref
Carl Turesson. 2010. Targeted Treatment of the Rheumatic Diseases. Targeted Treatment of the Rheumatic Diseases
38
45
.
Larry W. Moreland & Jeffrey R. Curtis. (2009) Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms. Seminars in Arthritis and Rheumatism 39:2, pages 132-143.
Crossref
Crossref
C. Egla Rabinovich, Edward Fels, Joseph Shanahan, J. Marc Majure & Thomas M. Murphy. 2009. Pulmonary Manifestations of Pediatric Diseases. Pulmonary Manifestations of Pediatric Diseases
201
240
.
Evangelos M. Davas, Ioannis Alexiou, Mary Boulbou, Athanasios Koutroumpas, Konstantinos Makaritsis, Nikolaos Stathakis & Lazaros I. Sakkas. (2008) Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFα inhibitors. Journal of Infection 57:5, pages 418-420.
Crossref
Crossref
Johan Askling & Will Dixon. (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Current Opinion in Internal Medicine 7:3, pages 301-307.
Crossref
Crossref
Johan Askling & Will Dixon. (2008) The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Current Opinion in Rheumatology 20:2, pages 138-144.
Crossref
Crossref
Kaleb Michaud & Frederick Wolfe. (2007) Comorbidities in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 21:5, pages 885-906.
Crossref
Crossref